For over 45 years, we have been pursuing with passion, the goal of giving women with breast cancer back their self-confidence. Since 1975, we have been supporting women as a proficient partner in breast care, with the highest standards of quality, innovation and design. Patents for materials and manufacturing methods are proof of our progress. However, this is by no means the end of the story. In the future, we will continue to listen carefully to affected women and our specialist retailers, and we will continue to develop our product range. All of our products are perfectly tailored to the needs of women with breast cancer - to date, we have sold over 17 million breast forms and 34 million breast care textiles. We are proud to accompany women throughout their recovery journey, from diagnosis to a return to normal life.
Today, around 400 employees worldwide (with 200 of them at our headquarters in Raubling, Bavaria), work with full commitment and passion to achieve this goal. With 15 subsidiaries and a comprehensive network of distributors, we are represented in more than 70 countries.
Breast cancer is the most commonly diagnosed cancer in women, with 2 million new cases worldwide each year. In the course of their lives, an average of one in eight women will develop breast cancer. Statistically, most sufferers are diagnosed between the ages of 50 and 60. With thanks to good diagnostics, advanced treatment options and surgical interventions, the 5-year relative survival rate is now 90%. However, a lot changes for those affected after a breast cancer diagnosis. The diagnosis is followed by a surgical removal of the tumour and if necessary, the affected lymph nodes.
Today, around 70% of women undergo breast-conserving surgery and of an estimated 30% of those cases, the entire breast is removed. 40 - 60% of women who have had breast-conserving surgery have a second operation. The reason for this is the recurrence of symptoms or because the optical result is not satisfactory. This applies to 10-40% of women worldwide.
Since surgery and follow-up treatments are often serious procedures, the risk of secondary diseases also increases. Approximately 20-30% of women who have breast surgery, develop arm or thoracic lymphedema following their treatments.
At Amoena, our goal is to develop and offer products that improve the quality of life of affected women.
Breast cancer is by far the most common cancer in women. Therefore, it could be assumed that women receive comprehensive information and detailed counselling after a diagnosis. Unfortunately, this is not always the case - as we are told time and again.
The diagnosis of 'breast cancer' is only the first step, which is then followed by an almost unmanageable number of contacts, treatments and follow-up therapies. As good as the aftercare may be, the flow of information between each category, does not often take place. We have set ourselves the goal of closing this gap through the close exchange between doctors, therapists, specialists and affected women.
We strive to support the confidence of women after breast surgery and accompany them on their individual journey through life - we are there, from the diagnosis all the way back to a normal life. Through strong and close relationships, we inspire, empower and support. Our medical retailers and medical professionals are trained and equipped with innovative solutions. We want to ensure that our female customers receive the best possible service and products that are bespoke to their needs.
(1) https://www.who.int/news-room/fact-sheets/detail/breast-cancer
(2) https://gco.iarc.fr/today/;
(3) https://www.webmd.com/breast-cancer/breast-cancer-survival-rates;
(4) https://www.medicalnewstoday.com/articles/325654#risks-at-different-ages;
(5) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504664/;
(6) https://pubmed.ncbi.nlm.nih.gov/29605247/;
(7) https://pubmed.ncbi.nlm.nih.gov/18259820/;
(8) https://www.oatext.com/lymphedema-following-breast-cancer-the-importance-of-surgical-methods-and-obesity.php#gsc.tab=0
